Literature DB >> 16160140

Adenovirus receptors.

Yuanming Zhang1, Jeffrey M Bergelson.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16160140      PMCID： PMC1211528          DOI： 10.1128/JVI.79.19.12125-12131.2005

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  103 in total

1.  A human cell line selected for resistance to adenovirus infection has reduced levels of the virus receptor.

Authors:  P Freimuth
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

2.  Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5.

Authors:  J M Bergelson; J A Cunningham; G Droguett; E A Kurt-Jones; A Krithivas; J S Hong; M S Horwitz; R L Crowell; R W Finberg
Journal:  Science       Date:  1997-02-28       Impact factor: 47.728

3.  Comparative analysis of adenovirus fiber-cell interaction: adenovirus type 2 (Ad2) and Ad9 utilize the same cellular fiber receptor but use different binding strategies for attachment.

Authors:  P W Roelvink; I Kovesdi; T J Wickham
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

4.  Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain.

Authors:  S C Stevenson; M Rollence; B White; L Weaver; A McClelland
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

5.  Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells.

Authors:  S Huang; T Kamata; Y Takada; Z M Ruggeri; G R Nemerow
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

6.  P-selectin and vascular cell adhesion molecule-1 are focally expressed in aortas of hypercholesterolemic rabbits before intimal accumulation of macrophages and T lymphocytes.

Authors:  A Sakai; N Kume; E Nishi; K Tanoue; M Miyasaka; T Kita
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-02       Impact factor: 8.311

7.  Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus.

Authors:  N Okada; M K Liszewski; J P Atkinson; M Caparon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

8.  Epitopes and hemagglutination binding domain on subgenus B:2 adenovirus fibers.

Authors:  Y F Mei; G Wadell
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

9.  Adenovirus type 5 and 7 capsid chimera: fiber replacement alters receptor tropism without affecting primary immune neutralization epitopes.

Authors:  J Gall; A Kass-Eisler; L Leinwand; E Falck-Pedersen
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

10.  MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.

Authors:  Y Yang; H C Ertl; J M Wilson
Journal:  Immunity       Date:  1994-08       Impact factor: 31.745
View more
  101 in total

1.  Effective high-capacity gutless adenoviral vectors mediate transgene expression in human glioma cells.

Authors:  Marianela Candolfi; James F Curtin; Wei-Dong Xiong; Kurt M Kroeger; Chunyan Liu; Altan Rentsendorj; Hasmik Agadjanian; Lali Medina-Kauwe; Donna Palmer; Philip Ng; Pedro R Lowenstein; Maria G Castro
Journal:  Mol Ther       Date:  2006-06-23       Impact factor: 11.454

2.  Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: implications for clinical efficacy.

Authors:  Matthieu Perreau; Franck Mennechet; Nicolas Serratrice; Joel N Glasgow; David T Curiel; Harald Wodrich; Eric J Kremer
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

Review 3.  Learning from the viral journey: how to enter cells and how to overcome intracellular barriers to reach the nucleus.

Authors:  Diky Mudhakir; Hideyoshi Harashima
Journal:  AAPS J       Date:  2009-02-05       Impact factor: 4.009

4.  A rapid protocol for construction and production of high-capacity adenoviral vectors.

Authors:  Lorenz Jager; Martin A Hausl; Christina Rauschhuber; Nicola M Wolf; Mark A Kay; Anja Ehrhardt
Journal:  Nat Protoc       Date:  2009       Impact factor: 13.491

5.  Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement.

Authors:  Zhili Xu; Jie Tian; Jeffrey S Smith; Andrew P Byrnes
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

6.  Transposon-assisted cloning and traceless mutagenesis of adenoviruses: Development of a novel vector based on species D.

Authors:  Zsolt Ruzsics; Markus Wagner; Andrea Osterlehner; Jonathan Cook; Ulrich Koszinowski; Hans-Gerhard Burgert
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

Review 7.  Adenoviral vector-mediated gene therapy for gliomas: coming of age.

Authors:  Maria G Castro; Marianela Candolfi; Thomas J Wilson; Alexandra Calinescu; Christopher Paran; Neha Kamran; Carl Koschmann; Mariela A Moreno-Ayala; Hikmat Assi; Pedro R Lowenstein
Journal:  Expert Opin Biol Ther       Date:  2014-04-29       Impact factor: 4.388

8.  Human adenovirus type 37 and the BALB/c mouse: progress toward a restricted adenovirus keratitis model (an American Ophthalmological Society thesis).

Authors:  James Chodosh
Journal:  Trans Am Ophthalmol Soc       Date:  2006

Review 9.  Platelets and viruses: an ambivalent relationship.

Authors:  Claire Flaujac; Siham Boukour; Elisabeth Cramer-Bordé
Journal:  Cell Mol Life Sci       Date:  2009-12-12       Impact factor: 9.261

Review 10.  New insights on adenovirus as vaccine vectors.

Authors:  Marcio O Lasaro; Hildegund C J Ertl
Journal:  Mol Ther       Date:  2009-06-09       Impact factor: 11.454
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.